Navigation Links
Delcath Announces Agreement With European Institute of Oncology for Initial Launch of Hepatic Chemosat Delivery System in the European Union
Date:11/21/2011

a prestigious institution as the IEO, one of Europe's premier cancer treatment and research facilities. We expect to announce similar agreements with other major cancer centers in Europe in the near future, which will position us well to begin realizing the potential of the CHEMOSAT system in 2012."

About the IEOThe European Institute of Oncology was established in 1994 to implement an innovative model for health and advanced research in the international oncology field. The IEO's mission is focused on state-of-the-art cancer research and treatment, from basic laboratory research that grapples with the genetic roots of cancer, to advanced clinical research such as testing new drugs, all with the unifying goal of finding ways to treat patients more effectively.

About Delcath SystemsDelcath Systems, Inc. is a development stage specialty pharmaceutical and medical device company focused on oncology. Delcath's proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents. The Company's initial focus is on the treatment of primary and metastatic liver cancers. In 2010, Delcath concluded a Phase III metastatic melanoma study, and the Company recently completed a multi-arm Phase II trial to treat other liver cancers. The Company obtained authorization to affix a CE Mark for the Hepatic CHEMOSAT delivery system in April 2011. The Company has not yet received FDA approval for commercial sale of its system in the United States. For more information, please visit the Company's website at http://www.delcath.com/.

The Private Securities Litigation Reform Act of 1995 provides a safe harbor for forward-looking statements made by the Company or on its behalf. This news release contains forward-looking statements, which are subject to certain risks a
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Delcath to Present at the Lazard Healthcare Conference on November 15
2. Delcath Announces Fiscal 2011 Third Quarter Results and Recent Developments
3. Delcath Systems to Report Third Quarter Progress and Conduct Conference Call
4. FDA Schedules Delcath Pre-New Drug Application Meeting Date
5. Delcath Announces Completion of Regulatory Notification Process in New Zealand
6. Delcath Announces Updated Efficacy Results From Phase 3 Trial of Chemosaturation for Melanoma Metastases in the Liver Presented at European Multidisciplinary Cancer Congress
7. Delcath to Present at the JMP Securities Healthcare Conference on September 28, 2011
8. Delcath Systems, Inc. Hosts Symposium on Chemosaturation at CIRSE Annual Meeting
9. Delcath Announces Top-Line Results From Metastatic Colorectal Cohort in Phase II Trial of Chemosaturation System
10. Delcath Announces Encouraging Top-Line Results From Hepatobiliary Cohort in Phase II Trial of Chemosaturation System
11. Delcath to Present at the Wedbush 2011 Life Sciences Conference on August 16, 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... REDMOND, Wash. , July 28, 2015 ... ingestion of Nutraceutix,s L. reuteri probiotic enriches ... factors that increase insulin secretion.  The study involved daily ... strain SD-5865) in tablets using the patented BIO- tract ... from damage by stomach acid on their way to ...
(Date:7/28/2015)...  SeraCare Life Sciences, a leading partner to ... the American Association of Clinical Chemistry (AACC) meeting ... the University of California, San Francisco (UCSF) for ... (T18) and Trisomy 13 (T13) trophoblast cell line ... materials for Non-Invasive Prenatal Testing (NIPT) of chromosomal ...
(Date:7/28/2015)... 2015 The Physician-Patient Alliance for Health & ... " Surviving Your Hospital Stay ." "Help ... None of these patients went home from hospital," said ... PPAHS) referring to the patient stories presented ... to Promote Continuous Monitoring of Patients on Opioids ...
Breaking Medicine Technology:Nutraceutix's L. reuteri Probiotic Clinically Proven to Modulate Gut Insulin Metabolism 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 2SeraCare Life Sciences Signs License Agreement with UCSF and Announces Early Access Program for Development of Aneuploidy Reference Materials 3Surviving Your Hospital Stay: Physician-Patient Alliance for Health & Safety Launches Fundraising for Patient Safety 2
... FOREST, Ill., Feb. 3, 2011 Hospira, Inc. (NYSE: ... injectable pharmaceuticals, today announced U.S. Food and Drug Administration ... of the oncology drug approved in the United States. ... had 2010 U.S. sales of more than $140 million. ...
... Medical, a leading designer of integrated medical imaging display ... Carrot Medical achieved significant growth in sales, an expansion ... Carrot Medical, recognized as a market leader, is ... integrates medical images and other visual data onto a ...
Cached Medicine Technology:Hospira Announces FDA Approval of Topotecan Injection 2Carrot Medical Reports 2010 Growth in Sales and Financing, Optimism for 2011 2
(Date:7/28/2015)... ... , ... City Sports, a specialty sports retailer and a premiere destination for ... CEO. , Hanaka, who has served on the Board of Directors for City Sports ... Consumer Fund has had previous tenures as Chairman and CEO of Golfsmith International Holdings, ...
(Date:7/28/2015)... ... July 28, 2015 , ... ProFont is back with a whole ... With ProFont: Cursive users can generate a hand drawn feel all with a click ... Users can select from either the upper and lowercase alphabet, special characters, numbers, and ...
(Date:7/28/2015)... ... 28, 2015 , ... World Patent Marketing, a vertically integrated ... cleans pools efficiently - minus the backbreaking work. , "The Swimming Pool Cleaning ... of World Patent Marketing. "It is a sleeping giant that has woken up ...
(Date:7/28/2015)... FL (PRWEB) , ... July 28, 2015 , ... ... and The Miriam Hospital examines outcomes for inmates who continued methadone maintenance treatment ... latter group was more likely to relapse to opiate use (1) and more ...
(Date:7/28/2015)... ... , ... By 2016, the number of smartphones worldwide will surpass 2 billion. ... highly personal basis, increasing customer loyalty. However, capitalizing on this is not always obvious. ... to more nimble competitors. , The Open Mobile Summit 2015 is an influential gathering ...
Breaking Medicine News(10 mins):Health News:City Sports Names Marty Hanaka CEO 2Health News:Announcing ProFont Cursive from FCPX Effects developer Pixel Film Studios 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 2Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 3Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 4Health News:10 Fascinating Things You Never Knew About Swimming Pools Is Introduced by World Patent Marketing and Skimmer Helper 5Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 2Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 3Health News:Novus Medical Detox Center Analyzes Methadone Study Findings and Implications for Opiate Abuse Treatment 4Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 2Health News:Open Mobile Media: Etsy, Google, The Weather Company, CBS, TaskRabbit and New York Times: Moving from Web to Mobile-First 3
... the use of conditioning regimens of non-myeloablative ... toxic effects extends the possibility of hematopoietic-cell// ... and those with coexisting conditions. ... major problem after non-myeloablative transplantation. Death due ...
... Professor Ashley Woodcock and his team from the University of ... the pillows they analyzed. These fungi act as a trigger ... reported in the Journal Allergy. Researchers collected samples from 5 ... Researchers found that all the 10 pillows studied had a ...
... the deadly HIV/AIDS is accelerating in China with 126,808 ... patients, according to latest health reports//. Experts estimate that ... 80,000 AIDS patients. ,This is considerably higher than the ... over a margin of 19,818. In addition, the patients ...
... the first home based rapid HIV strip test kit. The result ... test without any physician or clinician help//. This new OraQuick test ... go public after FDA approval. This is a strip test, in ... two lines implies infection and the person is positive for HIV. ...
... associated with many adverse health consequences. The rapid ... population emphasizes the importance of environmental factors on ... make up one environmental component that has been ... the eating behaviors of children in a variety ...
... been designated as the National Dental Hygiene Month (NDHM) ... that it would be focusing on the relation between ... whole time//. ,Using tobacco or tobacco products is ... oral cancer. Smoking increases the chances of developing cancer ...
Cached Medicine News:Health News:Protective regimen for acute Graft-versus-host disease 2Health News:Fungal spores in the pillows can trigger an asthma attack 2Health News:Home Based Rapid HIV Test Kit to be approved by US – OraQuick Test Ki 2Health News:Increased Monitoring By Parents May Result In Lower BMI In Children 2
... 1000 assays are designed for ... IMMULITE 1000, continuous random access ... in both design and operation. ... in a wide variety of ...
... is devoid of any biological activity but ... structural integrity of insulin. Although insulin and ... equimolar concentrations, fasting levels of C-Peptide are ... owing to the longer half-life of C-Peptide. ...
Inquire...
Measles IgG ELISA test system is designed for the qualitative detection of IgG antibodies to Measles (Rubeola) virus in human serum, and is for in vitro diagnostic use....
Medicine Products: